APA (7th ed.) Citation

Ang, L., Guo, L., Wang, J., Huang, J., Lou, X., & Zhao, M. (2020). Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer. Cancer Letters, 479, 42. https://doi.org/10.1016/j.canlet.2020.03.012

Chicago Style (17th ed.) Citation

Ang, Lin, Lingli Guo, Jin Wang, Jin Huang, Xiaoli Lou, and Min Zhao. "Oncolytic Virotherapy Armed with an Engineered Interfering LncRNA Exhibits Antitumor Activity by Blocking the Epithelial Mesenchymal Transition in Triple-negative Breast Cancer." Cancer Letters 479 (2020): 42. https://doi.org/10.1016/j.canlet.2020.03.012.

MLA (9th ed.) Citation

Ang, Lin, et al. "Oncolytic Virotherapy Armed with an Engineered Interfering LncRNA Exhibits Antitumor Activity by Blocking the Epithelial Mesenchymal Transition in Triple-negative Breast Cancer." Cancer Letters, vol. 479, 2020, p. 42, https://doi.org/10.1016/j.canlet.2020.03.012.